GlassScriptPhysician profile
Ashley Surles
NPI 1093206278
$3,686.31
in general payments reported to CMS, 2019-2025
15 companies · $3,316 in 2025
The $3,316 reported for 2025 was more than what 96% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $37.36 · 2021: $40.34 · 2022: $98.02 · 2023: $176 · 2024: $19.37 · 2025: $3,316.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,100 · Food and Beverage: $251 · Travel and Lodging: $160.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,099.99 |
| Food and Beverage | $250.65 |
| Travel and Lodging | $159.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,176.94 | 2025 | |
| Astellas Pharma US INC | $99.99 | 2023 | |
| Abbvie INC. | $92.85 | 2022-2024 | Orilissa, Lo Loestrin Fe |
| Takeda Pharmaceuticals U.S.A., INC. | $61.52 | 2022-2023 | Trintellix |
| Hologic Sales and Service, LLC | $45.90 | 2025 | Myosure Tissue Removal Device, Aptima |
| Allergan, INC. | $39.74 | 2020-2021 | |
| Amag Pharmaceuticals, INC. | $23.61 | 2020 | |
| Coopersurgical, INC. | $22.45 | 2025 | Endosee |
| Sumitomo Pharma America, INC. | $21.02 | 2023 | Myfembree |
| Organon LLC | $20.13 | 2025 | Jada System |
| Minerva Surgical, INC | $20.12 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.71 | 2022 | |
| Pfizer INC. | $15.39 | 2025 | |
| Ethicon US, LLC | $14.59 | 2025 | Enseal |
| Therapeuticsmd, INC. | $14.35 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Surles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.